Dual CD33-CLL1-CAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT05016063 · UNKNOWN

Trial details

NCT number: NCT05016063
Sponsor: Xinqiao Hospital of Chongqing
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2021-09-01
Primary completion: 2022-09-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.